Day 2 Track 1
Policy Considerations for Adopting and Expanding Telehealth at Your Cancer Program
Frank Micciche, Vice President, Public Policy and Communications, National Committee for Quality Assurance
Feyi Olopade Ayodele, MBA, Chief Executive Officer, Cancer IQ, Inc.
Mei Wa Kwong, JD, Executive Director, Center for Connected Health Policy
Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client and Corporate Resources, Revenue Cycle Coding Strategies (Moderator)
This panel conversation will explore policy considerations for cancer programs looking to expand and sustain their telehealth services. Panelists will discuss reimbursement and regulatory barriers, lessons learned and opportunities in the current era, the status of provisions after the public health emergency ends, healthcare disparities, and the policies that are still required to ensure long-term adoption of telehealth.
Virtual Solutions: Oncology Telemedicine for Rural Communities
Johanna Garzon, MHA, HBAT, Cancer Center Director, Central Care Cancer Center and Heartland Cancer Center
While most cancer programs adopted telehealth virtually overnight, challenges still exist, and lessons learned from telehealth programs established pre-pandemic can help. Hear strategies to address challenges around access to technology, socio-economic barriers, and standardization. Learn how to improve health equity by ensuring non-English speaking patients and those with limited financial resources can effectively access these services.
The Role of Remote Cancer Symptom Management in An Evolving Reimbursement Landscape
Ethan Basch, MD, MSc, Chief, Division of Oncology; Physician-in-Chief NC Cancer Hospital; Professor, Health Policy and Management, UNC Gillings School of Global Public Health; Director, Cancer Outcomes Research Program; Co-Leader, Cancer Prevention and Control Program, Control Program, Lineberger Comprehensive Cancer Center
Nadia Still, DNP, RN, Senior Director of Client Services, Carevive Systems, Inc.
Madelyn Trupkin Herzfeld, Founder and Vice Chair, Carevive Systems, Inc.
Bruno Lempernesse, Chief Executive Officer, Carevive Systems, Inc.
Learn about the latest research findings on patient-reported outcomes (PROs), the role of remote symptom management (RSM) in an evolving reimbursement landscape, how to implement RSM in your practice, and how to use insights from patient experience data to inform the future of cancer care.
Prevention on the Go—Workplace
Renea Austin-Duffin, MPA, Vice President, Cancer Support, Outreach & Clinical Research, Mary Bird Perkins Cancer Center
With the precipitous drop in screenings in the spring of 2020, COVID-19 has had a catastrophic impact on cancer screening and prevention. Learn from the changes this program made to continue to offer these critical services to at-risk patients, including education on how mobile vans can offer a safe—and more comfortable— alternative for people hesitant to return to the clinic.